Arno Therapeutics Inc (ARNI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile
April 2017
33
About the Report
About the Report
Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the treatment of breast and endometrial cancer) with Invivis Pharmaceuticals, Inc.; AR-42 (for hematological malignancies and solid tumors); and AR-12, (for solid tumors and lymphoma) with the Ohio State University. These compounds are in clinical or preclinical stages of development. The company has agreements with pharmaceutical companies and research institutes to develop its product portfolio. Arno Therapeutics is headquartered in Flemington, New Jersey, the US.
Arno Therapeutics Inc (ARNI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Arno Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Arno Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Arno Therapeutics Enters into R&D Agreement with US Army Medical Research Institute of Infectious Diseases 12
Licensing Agreements 12
Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 12
Arno Therapeutics Enters into Licensing Agreement with Invivis Pharma for Onapristone 13
Equity Offering 14
Arno Therapeutics to Raise Funds through Public Offering of Shares 14
Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 15
Arno Therapeutics Raises USD5.3 Million in Private Placement of Shares 17
Arno Therapeutic Raises USD5.3 Million in Private Placement of Shares 18
Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 19
Debt Offering 21
Arno Therapeutics Raises USD2 Million in Private Placement of 6% Notes Due 2016 21
Arno Therapeutics Completes Private Placement Of Debentures Due 2015 For Additional US$2 Million 21
Asset Transactions 22
Vivacitas Oncology Acquires Preclinical and Clinical Data Package from Arno Therapeutics 22
Arno Therapeutics Inc-Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Nov 14, 2016: Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update 27
Aug 22, 2016: Arno Therapeutics Reports Second Quarter 2016 Financial and Business Update 28
May 16, 2016: Arno Therapeutics Reports First Quarter 2016 Financial and Business Update 29
Mar 30, 2016: Arno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update 30
Clinical Trials 31
Apr 19, 2016: Arno Therapeutics to Focus Clinical Developmental Activities on Advanced Prostate Cancer in First-of-its-Kind Phase II Study of Onapristone in Combination with ZYTIGA 31
Mar 21, 2016: Arno Therapeutics Advances Phase I/II Trial Evaluating Onapristone in Prostate Cancer to Phase II 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Figure
List of Figures
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
List of Table
List of Tables
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Arno Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Arno Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Arno Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Arno Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Arno Therapeutics Enters into R&D Agreement with US Army Medical Research Institute of Infectious Diseases 12
Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 12
Arno Therapeutics Enters into Licensing Agreement with Invivis Pharma for Onapristone 13
Arno Therapeutics to Raise Funds through Public Offering of Shares 14
Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 15
Arno Therapeutics Raises USD5.3 Million in Private Placement of Shares 17
Arno Therapeutic Raises USD5.3 Million in Private Placement of Shares 18
Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 19
Arno Therapeutics Raises USD2 Million in Private Placement of 6% Notes Due 2016 21
Arno Therapeutics Completes Private Placement Of Debentures Due 2015 For Additional US$2 Million 21
Vivacitas Oncology Acquires Preclinical and Clinical Data Package from Arno Therapeutics 22
Arno Therapeutics Inc, Key Competitors 24
Arno Therapeutics Inc, Key Employees 25
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.